Cargando…

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou

Detalles Bibliográficos
Autores principales:	Adegunsoye, Ayodeji, Baccile, Rachel, Best, Thomas J., Zaksas, Victoria, Zhang, Hui, Karnik, Rasika, Patel, Bhakti K., Solomonides, Anthony E., Parker, William F., Solway, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565760/ https://www.ncbi.nlm.nih.gov/pubmed/37829195 http://dx.doi.org/10.1016/j.lana.2023.100611

Ejemplares similares

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Response to Zhou and Robinson
por: Betel, Doron, et al.
Publicado: (2015)

Reply to Wang and Zhou
por: Jandl, Katharina, et al.
Publicado: (2023)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

Letter to the Editor in Response to Zhou et al
por: Troth, Sean, et al.
Publicado: (2021)

First person – Jianhao Zeng
Publicado: (2023)

Reply to Liu and Zhou: Association of Sex Steroid Hormones with Adult Asthma in the United States, 2013–2016
por: Han, Yueh-Ying, et al.
Publicado: (2020)

Yi Zeng: promoting good governance of artificial intelligence
por: Jia, Hepeng
Publicado: (2020)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
por: Zeng, Guangting, et al.
Publicado: (2023)

Guang Zeng, China CDC’s Former Chief Expert of Epidemiology
por: Hao, Peter, et al.
Publicado: (2020)

Reply to Shao and Zhou
por: Gagelmann, Nico, et al.
Publicado: (2022)

Inflammatory Response Mechanisms Exacerbating Hypoxemia in Coexistent Pulmonary Fibrosis and Sleep Apnea
por: Adegunsoye, Ayodeji, et al.
Publicado: (2015)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

DGI recommendations for COVID-19 pharmacotherapy
por: Malin, Jakob J., et al.
Publicado: (2020)

Dr. Yi Zeng (1929−2020) A Pioneer on HIV and Tumor Virology in China
por: Zhang, Xiaoguang, et al.
Publicado: (2020)

DMM Prize 2018 winner: Wenqing Zhou
por: Justice, Monica J.
Publicado: (2019)

In Mourning and Memory of Late Professor Zhou Jun
por: Liu, Ji-Kai, et al.
Publicado: (2021)

Stem cells and art: an interview with Yi Arial Zeng on the promising future of the stem cell field
Publicado: (2021)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Network Pharmacological Analysis and Animal Experimental Study on Osteoporosis Treatment with GuBen-ZengGu Granules
por: Wang, Kai, et al.
Publicado: (2023)

Professor Huakang Zhou: Dedicated himself to pediatrics in China
por: Yong, Weizhe
Publicado: (2018)

In Memory of the Late Professor Jun Zhou (1932–2020)
por: Hao, Xiao-Jiang
Publicado: (2021)

SARS-CoV-2 Infection Is Associated with Reduced Krüppel-like Factor 2 in Human Lung Autopsy
por: Wu, David, et al.
Publicado: (2021)

Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19
por: Duan, Kai, et al.
Publicado: (2020)

Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Ishida, Yuriko, et al.
Publicado: (2022)

Computer-Aided Pulmonary Fibrosis Detection Leveraging an Advanced Artificial Intelligence Triage and Notification Software
por: Selvan, Kavitha C., et al.
Publicado: (2023)

Dr. Jian Zhou: The great inventor of cervical cancer vaccine
por: Zhao, Kong-Nan, et al.
Publicado: (2017)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Erratum for Zeng et al., “Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H”
por: Zeng, Cong, et al.
Publicado: (2021)

Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Nici, Linda, et al.
Publicado: (2020)

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders
por: Adegunsoye, Ayodeji, et al.
Publicado: (2012)

Bogus "M.Ds."
por: Karnik, C. H.
Publicado: (1929)

Hospitalizations in patients with idiopathic pulmonary fibrosis
por: Kim, Hyun J., et al.
Publicado: (2021)

Therapeutic Approach to Adult Fibrotic Lung Diseases
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
por: Khor, Yet H., et al.
Publicado: (2022)

Complete mitochondrial genome of Morphostenophanes sinicus (Zhou, 2020) (Insecta: Coleoptera: Tenebrionidae)
por: Bai, Yu, et al.
Publicado: (2021)

Passion for moments and compassion for patients: in memory of Dr. Jianfeng Zhou (1966–2022)
por: Qiu, Lugui, et al.
Publicado: (2022)

The life of Xuan Zhou, founding father of the Gastrodia elata cultivation and industry in China
por: Wang, Jian
Publicado: (2023)

Disregarding ZooBank registration results in the unavailability of Hemicaloosia graminis Zeng et al., 2012 (Nematoda, Tylenchida) under the ICZN Code
por: Inserra, R. N., et al.
Publicado: (2013)

Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lei10ltnkeek3jl0vfe9rhi9d0